Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous Methimazole in Radioiodine Therapy
NCT00150137Phase 4Completed
- Sponsor
- University Hospital Odense
- Start
- Jan 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methimazole in Graves' disease, toxic nodular goiter (TNG), sponsored by University Hospital Odense. Started Jan 2003; status: completed.
02
Drugs
methimazole
03
Conditions
Graves' diseasetoxic nodular goiter (TNG)
Beyond the preview
Go deeper on NCT00150137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00150137.